View More Recent Stories
-
GeneDx names Lisa Gurry as chief business officer
-
GeneDx (WGS) PT Raised at Piper Sandler; 'We Recommend Buying More on a Pullback'
-
Piper Sandler on GeneDx (WGS): 'Visibility to a Multiyear Growth Cycle'
-
GeneDx (WGS) PT Raised to $125 at BTIG
-
GeneDx Holdings (WGS) Tops Q2 EPS by 38c ; Offers Guidance
-
ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
Piper Sandler Starts GeneDx (WGS) at Overweight
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
GeneDx (WGS) PT Raised to $105 at Jefferies
-
GeneDx (WGS) announces AAP now recommends exome and genome sequencing
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
GeneDx Holdings (WGS) spreader July 70 and 80 calls as share price down 5.7%
-
Jefferies Upgrades GeneDx (WGS) to Buy
-
GeneDx Holdings (WGS) call put ratio 1 call to 1.3 puts as share price down
-
GeneDx (WGS) PT Lowered to $100 at BTIG
-
Increasing unusual put option volume: WGS WEN SCCO VNQ IP BBIO URNM BXP TTE SNAP FSLR NE
-
GeneDx Holdings (WGS) Misses Q1 EPS by 29c ; Offers Guidance
-
GeneDx to Acquire Fabric Genomics
-
TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
-
GeneDx Holdings (WGS) 6900 contracts trade compared to 90-day average of 442 contracts as share price up 38%
-
GeneDx Holdings (WGS) Reports Q4 results; offers guidance
-
GeneDx Holdings (WGS) Announces ultraRapid Whole Genome Sequencing
-
GeneDx Integrates with Epic through launch on Aura
-
Craig-Hallum on GeneDx Holdings (WGS): 'Would Buy on Weakness' (Tuesday)
-
Jefferies Reiterates Hold Rating on GeneDx (WGS)
-
BTIG Defending GeneDx (WGS)
-
Grizzly Research is short GeneDx Holdings (WGS)
-
GeneDx (WGS) Announces Preliminary 2024 Financial Results
-
GeneDx (WGS) PT Raised to $118 at TD Cowen, Citing 'Strong Competitive Position'
-
GeneDx Holdings (WGS) Appoints Bryan Dechairo as COO
-
GeneDx Holdings (WGS) Misses Q3 EPS by 31c
-
GeneDx Holdings (WGS) December 85 calls active as share price up 44%
-
GeneDx (WGS) PT Raised to $50 at TD Cowen
-
GeneDx (WGS) PT Raised to $45 at BTIG
-
GeneDx Holdings (WGS) Misses Q2 EPS by 46c; offers guidance
-
Craig-Hallum Starts GeneDx (WGS) at Buy
-
GeneDx (WGS) PT Raised to $35 at BTIG

